Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 130

1.

First six years of implementing colorectal cancer screening in the Osijek-Baranja County, Croatia--can we do better?

Samardzić S, Mihaljević S, Dmitrović B, Milas J, Puntarić D, Tadijan D, Jelić K.

Coll Antropol. 2013 Sep;37(3):913-8.

PMID:
24308237
2.

Results of National Colorectal Cancer Screening Program in Croatia (2007-2011).

Katičić M, Antoljak N, Kujundžić M, Stamenić V, Skoko Poljak D, Kramarić D, Stimac D, Strnad Pešikan M, Samija M, Ebling Z.

World J Gastroenterol. 2012 Aug 28;18(32):4300-7. doi: 10.3748/wjg.v18.i32.4300.

3.

Ontario's ColonCancerCheck: results from canada's first province-wide colorectal cancer screening program.

Rabeneck L, Tinmouth JM, Paszat LF, Baxter NN, Marrett LD, Ruco A, Lewis N, Gao J.

Cancer Epidemiol Biomarkers Prev. 2014 Mar;23(3):508-15. doi: 10.1158/1055-9965.EPI-13-0956. Epub 2014 Jan 17.

4.

Men with negative results of guaiac-based fecal occult blood test have higher prevalences of colorectal neoplasms than women with positive results.

Brenner H, Hoffmeister M, Birkner B, Stock C.

Int J Cancer. 2014 Jun 15;134(12):2927-34. doi: 10.1002/ijc.28618. Epub 2013 Dec 11.

5.

Experience with a two-tier reflex gFOBT/FIT strategy in a national bowel screening programme.

Fraser CG, Digby J, McDonald PJ, Strachan JA, Carey FA, Steele RJ.

J Med Screen. 2012 Mar;19(1):8-13. doi: 10.1258/jms.2011.011098. Epub 2011 Dec 7.

PMID:
22156144
6.

Adding familial risk assessment to faecal occult blood test can increase the effectiveness of population-based colorectal cancer screening.

Dekker N, van Rossum LG, Van Vugt-van Pinxteren M, van Stiphout SH, Hermens RP, van Zelst-Stams WA, van Oijen MG, Laheij RJ, Jansen JB, Hoogerbrugge N.

Eur J Cancer. 2011 Jul;47(10):1571-7. doi: 10.1016/j.ejca.2011.01.022. Epub 2011 Feb 28.

7.

Early detection of colorectal cancer with faecal occult blood test screening.

Paimela H, Malila N, Palva T, Hakulinen T, Vertio H, Järvinen H.

Br J Surg. 2010 Oct;97(10):1567-71. doi: 10.1002/bjs.7150.

PMID:
20603855
8.
9.

Colorectal cancer screening with the addition of flexible sigmoidoscopy to guaiac-based faecal occult blood testing: a French population-based controlled study (Wintzenheim trial).

Denis B, Gendre I, Aman F, Ribstein F, Maurin P, Perrin P.

Eur J Cancer. 2009 Dec;45(18):3282-90. doi: 10.1016/j.ejca.2009.06.015. Epub 2009 Aug 6.

PMID:
19665368
10.

Negative screening colonoscopy after a positive guaiac faecal occult blood test: not a contraindication to continued screening.

Carrera A, McClements PL, Watling C, Libby G, Weller D, Brewster DH, Carey FA, Fraser CG, Steele RJ.

Colorectal Dis. 2012 Aug;14(8):943-6. doi: 10.1111/j.1463-1318.2011.02849.x.

PMID:
21981347
11.

Optimising faecal occult blood screening:retrospective analysis of NHS Bowel Cancer Screening data to improve the screening algorithm.

Geraghty J, Butler P, Seaman H, Snowball J, Sarkar S, Blanks R, Halloran S, Bodger K, Rees CJ.

Br J Cancer. 2014 Nov 25;111(11):2156-62. doi: 10.1038/bjc.2014.480. Epub 2014 Sep 16.

13.
14.

Short term outcomes of the first round of a pilot colorectal cancer screening programme with guaiac based faecal occult blood test.

Denis B, Ruetsch M, Strentz P, Vogel JY, Guth F, Boyaval JM, Pagnon X, Ebelin JF, Gendre I, Perrin P.

Gut. 2007 Nov;56(11):1579-84. Epub 2007 Jul 6.

15.

Comparison of guaiac and immunological fecal occult blood tests in colorectal cancer screening: the patient perspective.

Deutekom M, van Rossum LG, van Rijn AF, Laheij RJ, Fockens P, Bossuyt PM, Dekker E, Jansen JB.

Scand J Gastroenterol. 2010 Nov;45(11):1345-9. doi: 10.3109/00365521.2010.497937. Epub 2010 Jun 21.

PMID:
20560814
16.

Guaiac versus immunochemical tests: faecal occult blood test screening for colorectal cancer in a rural community.

Hughes K, Leggett B, Del Mar C, Croese J, Fairley S, Masson J, Aitken J, Clavarino A, Janda M, Stanton WR, Tong S, Newman B.

Aust N Z J Public Health. 2005 Aug;29(4):358-64.

PMID:
16222934
17.

Risk for colorectal cancer in elderly persons and possible methodologies for their screening.

Rozen P, Shabtai EI, Liphshitz I, Barchana M.

Eur J Gastroenterol Hepatol. 2011 May;23(5):431-7. doi: 10.1097/MEG.0b013e328345bc38.

PMID:
21448071
18.

Random comparison of guaiac and immunochemical fecal occult blood tests for colorectal cancer in a screening population.

van Rossum LG, van Rijn AF, Laheij RJ, van Oijen MG, Fockens P, van Krieken HH, Verbeek AL, Jansen JB, Dekker E.

Gastroenterology. 2008 Jul;135(1):82-90. doi: 10.1053/j.gastro.2008.03.040. Epub 2008 Mar 25.

PMID:
18482589
19.

Screening for colorectal cancer: randomised trial comparing guaiac-based and immunochemical faecal occult blood testing and flexible sigmoidoscopy.

Hol L, van Leerdam ME, van Ballegooijen M, van Vuuren AJ, van Dekken H, Reijerink JC, van der Togt AC, Habbema JD, Kuipers EJ.

Gut. 2010 Jan;59(1):62-8. doi: 10.1136/gut.2009.177089. Epub .

PMID:
19671542
20.

Cost-effectiveness of population-based screening for colorectal cancer: a comparison of guaiac-based faecal occult blood testing, faecal immunochemical testing and flexible sigmoidoscopy.

Sharp L, Tilson L, Whyte S, O'Ceilleachair A, Walsh C, Usher C, Tappenden P, Chilcott J, Staines A, Barry M, Comber H.

Br J Cancer. 2012 Feb 28;106(5):805-16. doi: 10.1038/bjc.2011.580. Epub 2012 Feb 16.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk